Clinical Trials: Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain Study
This study is currently recruiting participants.
Verified by Mayo Clinic, November 2010
Further study details as provided by Mayo Clinic:
Primary Outcome Measures:
Improvement in pain control and quality of life [ Time Frame: 2 yrs ] [ Designated as safety issue: Yes ]
Secondary Outcome Measures:
Changes in urine biomarkers compared to pre-operation values within patients will be compared. Changes in kidney volume, kidney cyst volume, and kidney blood flow before and after the operation will be studied. [ Time Frame: 3 years ] [ Designated as safety issue: No ]
more info:
http://clinicaltrials.gov/ct2/show/NCT00571909?term=pkd&state1=NA:US:MN&rank=7